Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05306327

Neurologic Physiology After Removal of Therapy (NeuPaRT)

Neurologic Physiology After Removal of Therapy (NeuPaRT): Pilot Multicentre Feasibility Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
158 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine when brain function stops compared to when the heart stops by monitoring electrical brain activity in patients who are taken off life support and progress to death in the intensive care unit.

Detailed description

There are many Canadians who need an organ transplant and who will never get one. In the past, people could only be organ donors after being declared brain dead. The dead donor rule serves this purpose by ensuring that death determination precedes organ retrieval. In Canada, death determination occurs in one of two ways. In neurologic determination of death (NDD), death is declared upon completion of a standardized neurologic assessment that confirms permanent loss of brain activity. In donation after circulatory determination of death (DCDD), death is declared 5 minutes after circulatory arrest. By confirming permanent loss of brain activity, the current NDD process protects donors from suffering and maintains stakeholder trust. In contrast, the current DCDD process assumes, but does not explicitly confirm, permanent loss of brain activity when death is declared 5 minutes after circulatory arrest. While this assumption is rooted in a strong physiologic rationale, lack of compelling evidence regarding cessation of brain activity in humans contributes to ongoing mistrust of the DCDD process among healthcare and public stakeholders.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTelectroencephalography (EEG)1. brain cortical activity using full scalp 2. cerebral blood flow velocity 3. during the dying process following planned withdrawal of life sustaining measures (WLSM)

Timeline

Start date
2022-10-18
Primary completion
2027-03-01
Completion
2027-03-01
First posted
2022-04-01
Last updated
2026-01-30

Locations

5 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05306327. Inclusion in this directory is not an endorsement.